Denton David M

SEC source: 0000320187-26-000133 · form4.xml · derivative · entry 2

Denton David M · CIK 0001428718 · EVP: CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 259,946

Underlying: Class B Common Stock · 259,946 shares

Expires 2036-09-01

F2 · derivative.exercise_date: Stock Option granted under the NIKE, Inc. Stock Incentive Plan; it becomes exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant.

SEC source: 0000320187-26-000133 · form4.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · EVP: CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,234

F1 · kind: Restricted Stock Units ("RSUs") granted under the NIKE, Inc. Stock Incentive Plan; 25% of the total number of RSUs granted vest on each of the first four anniversaries of the date of the grant.

SEC source: 0001628280-26-053682 · wk-form4_1785972926.xml · derivative · entry 1

Denton David M · CIK 0001428718 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 572

Underlying: Common Stock · 572 shares

Expires not disclosed

F1 · derivative.exercise_price: Instrument converts to Issuer's Common Stock on a one-for-one basis.

F2 · derivative.exercise_date: The Restricted Stock Units shall vest on April 15, 2027.

F2 · derivative.expiration_date: The Restricted Stock Units shall vest on April 15, 2027.

SEC source: 0001628280-26-046684 · wk-form4_1782952269.xml · derivative · entry 2

Denton David M · CIK 0001428718 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135.1441

Underlying: Common Stock · 135.1441 shares

Expires not disclosed

F2 · derivative.exercise_price: Deferred Compensation (Phantom Shares) are allocated based on the price of HONA Common Stock on the contribution date by dividing the dollar amount of the contribution by the price per share of HONA Common Stock. Common Stock prices are based on the mean of the highest and lowest sales price on the date of contribution. Phantom Shares are settled in cash based on the price of HONA Common Stock at settlement.

F3 · derivative.exercise_date: Phantom shares are accrued under the Deferred Compensation Plan for Non-Employee Directors and will be settled in cash based on elections by the Reporting Person as permitted under the Plan.

F3 · derivative.expiration_date: Phantom shares are accrued under the Deferred Compensation Plan for Non-Employee Directors and will be settled in cash based on elections by the Reporting Person as permitted under the Plan.

SEC source: 0001225208-26-003315 · doc4.xml · derivative · entry 1

Denton David M · CIK 0001428718 · Chief Financial Officer & EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,537

Underlying: Common Stock · 216,537 shares

Expires 2031-03-03

F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

SEC source: 0001225208-25-003076 · doc4.xml · derivative · entry 1

Denton David M · CIK 0001428718 · Chief Financial Officer & EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 413,138

Underlying: Common Stock · 413,138 shares

Expires 2030-03-04

F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

SEC source: 0001225208-24-008706 · doc4.xml · derivative · entry 4

Denton David M · CIK 0001428718 · Chief Financial Officer & EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,703

Underlying: Common Stock · 80,703 shares

Expires 2029-05-31

F1 · shares: Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged.

F2 · derivative.expiration_date: Reflects a modification to the settlement date of the Modified TSRUs pursuant to the Modification Offer. The grant price and number of shares underlying the Modified TSRUs remain unchanged.

SEC source: 0001225208-24-008706 · doc4.xml · derivative · entry 3

Denton David M · CIK 0001428718 · Chief Financial Officer & EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 80,703 shares

Expires 2027-05-31

F1 · shares: Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged.

SEC source: 0001225208-24-008706 · doc4.xml · derivative · entry 2

Denton David M · CIK 0001428718 · Chief Financial Officer & EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,320

Underlying: Common Stock · 103,320 shares

Expires 2030-02-23

F1 · shares: Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged.

F2 · derivative.expiration_date: Reflects a modification to the settlement date of the Modified TSRUs pursuant to the Modification Offer. The grant price and number of shares underlying the Modified TSRUs remain unchanged.

SEC source: 0001225208-24-008706 · doc4.xml · derivative · entry 1

Denton David M · CIK 0001428718 · Chief Financial Officer & EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 103,320 shares

Expires 2028-02-23

F1 · shares: Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged.

SEC source: 0001225208-24-006527 · doc4.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · Chief Financial Officer & EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,919

F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).

SEC source: 0001225208-24-003208 · doc4.xml · derivative · entry 2

Denton David M · CIK 0001428718 · Chief Financial Officer & EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,400

Underlying: Common Stock · 142,400 shares

Expires 2031-02-27

F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

SEC source: 0001225208-24-003208 · doc4.xml · derivative · entry 1

Denton David M · CIK 0001428718 · Chief Financial Officer & EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,160

Underlying: Common Stock · 161,160 shares

Expires 2029-02-27

F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

SEC source: 0001225208-23-006419 · doc4.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · Chief Financial Officer & EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,224

F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).

SEC source: 0001225208-23-002810 · doc4.xml · derivative · entry 3

Denton David M · CIK 0001428718 · Chief Financial Officer & EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,920

Underlying: Common Stock · 89,920 shares

Expires 2030-02-23

F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

SEC source: 0001225208-23-002810 · doc4.xml · derivative · entry 2

Denton David M · CIK 0001428718 · Chief Financial Officer & EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,320

Underlying: Common Stock · 103,320 shares

Expires 2028-02-23

F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

SEC source: 0001225208-22-011759 · doc4.xml · derivative · entry 2

Denton David M · CIK 0001428718 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,822

Underlying: Common Stock · 6,822 shares

Expires 2032-11-15

F2 · security: All of the securities acquired were issued under the Issuer's Stock Incentive Plan.

SEC source: 0001225208-22-011759 · doc4.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,647

F1 · security: All of the securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 15, 2023.

SEC source: 0001225208-22-007553 · doc4.xml · derivative · entry 3

Denton David M · CIK 0001428718 · Chief Financial Officer & EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,313

Underlying: Common Stock · 70,313 shares

Expires 2029-05-31

F3 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

F3 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

SEC source: 0001225208-22-007553 · doc4.xml · derivative · entry 2

Denton David M · CIK 0001428718 · Chief Financial Officer & EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,703

Underlying: Common Stock · 80,703 shares

Expires 2027-05-31

F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

SEC source: 0001225208-22-007553 · doc4.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · Chief Financial Officer & EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,165

F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.

SEC source: 0000060667-22-000063 · wf-form4_164915878605331.xml · derivative · entry 5

Denton David M · CIK 0001428718 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,265

Underlying: Common Stock · 18,265 shares

Expires 2032-04-01

F5 · derivative.exercise_date: The option vests in three annual installments beginning on April 1, 2023.

SEC source: 0000060667-22-000063 · wf-form4_164915878605331.xml · derivative · entry 4

Denton David M · CIK 0001428718 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 38,220 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: At the vest date, the performance share units earned converted into an equivalent number of shares of the Issuer's common stock.

F4 · derivative.exercise_date: At the vest date, the performance share units earned converted into an equivalent number of shares of the Issuer's common stock.

F4 · derivative.expiration_date: At the vest date, the performance share units earned converted into an equivalent number of shares of the Issuer's common stock.

SEC source: 0000060667-22-000063 · wf-form4_164915878605331.xml · nonDerivative · entry 3

Denton David M · CIK 0001428718 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,663

F3 · shares: Restricted stock granted pursuant to 2006 Long-Term Incentive Plan. The shares will fully vest on April 1, 2025.

SEC source: 0000060667-22-000063 · wf-form4_164915878605331.xml · nonDerivative · entry 2

Denton David M · CIK 0001428718 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,313

F2 · shares: Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units and restricted shares granted on April 1, 2019.

SEC source: 0000060667-22-000063 · wf-form4_164915878605331.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,543

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each performance share unit represented a contingent right to receive one share of the Issuer's common stock upon the achievement of certain pre-established metrics over the three-year performance period ending at the end of fiscal 2021.

SEC source: 0000060667-22-000030 · wf-form4_164786377280034.xml · derivative · entry 1

Denton David M · CIK 0001428718 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,220

Underlying: Common Stock · 38,220 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of the Issuer's common stock. The performance share units were granted on April 1, 2019 and were subject to the achievement of certain pre-established metrics over the three-year performance period ending at the end of fiscal 2021. On March 17, 2022, the Compensation Committee of the Issuer's Board of Directors certified the performance metrics and determined the number of performance share units that were earned. The performance share units continue to be subject to a service condition that will be satisfied on April 1, 2022.

F1 · derivative.exercise_date: Each performance share unit represents a contingent right to receive one share of the Issuer's common stock. The performance share units were granted on April 1, 2019 and were subject to the achievement of certain pre-established metrics over the three-year performance period ending at the end of fiscal 2021. On March 17, 2022, the Compensation Committee of the Issuer's Board of Directors certified the performance metrics and determined the number of performance share units that were earned. The performance share units continue to be subject to a service condition that will be satisfied on April 1, 2022.

F1 · derivative.expiration_date: Each performance share unit represents a contingent right to receive one share of the Issuer's common stock. The performance share units were granted on April 1, 2019 and were subject to the achievement of certain pre-established metrics over the three-year performance period ending at the end of fiscal 2021. On March 17, 2022, the Compensation Committee of the Issuer's Board of Directors certified the performance metrics and determined the number of performance share units that were earned. The performance share units continue to be subject to a service condition that will be satisfied on April 1, 2022.

SEC source: 0000060667-22-000011 · wf-form4_164130017471718.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,323

F1 · shares: Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of restricted shares granted on January 2, 2019.

SEC source: 0001225208-21-013633 · doc4.xml · derivative · entry 2

Denton David M · CIK 0001428718 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,523

Underlying: Common Stock · 5,523 shares

Expires 2031-11-03

F2 · security: All of the securities acquired were issued under the Issuer's Stock Incentive Plan.

SEC source: 0001225208-21-013633 · doc4.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,162

F1 · security: All of the securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 3, 2022.

SEC source: 0000060667-21-000052 · wf-form4_161762581632040.xml · derivative · entry 2

Denton David M · CIK 0001428718 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,593

Underlying: Common Stock · 21,593 shares

Expires 2031-04-01

F2 · derivative.exercise_date: The option vests in three annual installments beginning on April 1, 2022.

SEC source: 0000060667-21-000052 · wf-form4_161762581632040.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,060

F1 · shares: Restricted stock granted pursuant to 2006 Long-Term Incentive Plan. The shares will fully vest on April 1, 2024.

SEC source: 0001225208-20-013192 · doc4.xml · derivative · entry 2

Denton David M · CIK 0001428718 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,282

Underlying: Common Stock · 7,282 shares

Expires 2030-11-05

F2 · security: All of the securities acquired were issued under the Issuer's Stock Incentive Plan.

SEC source: 0001225208-20-013192 · doc4.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,350

F1 · security: All of the securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 5, 2021.

SEC source: 0000060667-20-000063 · wf-form4_158594597157255.xml · derivative · entry 2

Denton David M · CIK 0001428718 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,141

Underlying: Common Stock · 57,141 shares

Expires 2030-04-01

F2 · derivative.exercise_date: The option vests in three annual installments beginning on April 1, 2021.

SEC source: 0000060667-20-000063 · wf-form4_158594597157255.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,400

F1 · shares: Restricted stock granted pursuant to 2006 Long-Term Incentive Plan. The shares will fully vest on April 1, 2023.

SEC source: 0001225208-19-014393 · doc4.xml · derivative · entry 2

Denton David M · CIK 0001428718 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,069

Underlying: Common Stock · 13,069 shares

Expires 2029-11-07

F2 · security: All of the securities acquired were issued under the Issuer's Stock Incentive Plan.

SEC source: 0001225208-19-014393 · doc4.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,210

F1 · security: All of the securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 7, 2020.

SEC source: 0000060667-19-000061 · wf-form4_155429430534045.xml · derivative · entry 2

Denton David M · CIK 0001428718 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,900

Underlying: Common Stock · 41,900 shares

Expires 2029-04-01

F2 · derivative.exercise_date: The option vests in three annual installments beginning on April 1, 2020.

SEC source: 0000060667-19-000061 · wf-form4_155429430534045.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,200

F1 · shares: Restricted stock granted pursuant to 2006 Long-Term Incentive Plan. The shares will fully vest on April 1, 2022.

SEC source: 0000060667-19-000015 · wf-form4_154660892589789.xml · derivative · entry 2

Denton David M · CIK 0001428718 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,700

Underlying: Common Stock · 40,700 shares

Expires 2029-01-02

F2 · derivative.exercise_date: The option vests in three annual installments beginning on January 2, 2020.

SEC source: 0000060667-19-000015 · wf-form4_154660892589789.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,650

F1 · shares: Restricted stock granted pursuant to 2006 Long-Term Incentive Plan. The shares will fully vest on January 2, 2022.

SEC source: 0001127602-18-034850 · form4.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 402.9767

F1 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.72 and $80.54 per share.

SEC source: 0001225208-18-015477 · doc4.xml · derivative · entry 2

Denton David M · CIK 0001428718 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,712

Underlying: Common Stock · 7,712 shares

Expires 2028-11-08

F2 · security: All of the securities acquired were issued under the Issuer's Stock Incentive Plan.

SEC source: 0001225208-18-015477 · doc4.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,361

F1 · security: All of the securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 8, 2019.

SEC source: 0001127602-18-013809 · form4.xml · derivative · entry 4

Denton David M · CIK 0001428718 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,767

Underlying: Common Stock · 116,767 shares

Expires 2025-04-01

F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2019.

SEC source: 0001127602-18-013809 · form4.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,494.99

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan.

SEC source: 0001127602-18-009717 · form4.xml · nonDerivative · entry 2

Denton David M · CIK 0001428718 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,102.99

F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.

SEC source: 0001127602-18-009717 · form4.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,715.99

F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.

SEC source: 0001127602-18-011887 · form4a.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,251.99

F1 · shares: Represents shares of stock issued under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan that are being held in constructive trust for the sole benefit of the reporting person's ex-spouse, pursuant to the terms of the separation agreement. Though originally reported on a Form 4 to be owned by the reporting person, these shares are actually considered to be owned by the ex-spouse and are not beneficially owned by the reporting person. The shares remain subject to a two-year holding period.